Methods for treating lymphomas using a combination of a chemotherapeutic agent and IL-2 and optionally an antiCD20 antibody

Details for Australian Patent Application No. 2006214244 (hide)

Owner Novartis Vaccines and Diagnostics Inc.

Inventors Denis-Mize, Kimberly; Heise, Carla; Wilson, Susan E.; Menezes, Daniel

Agent FB Rice

Pub. Number AU-A-2006214244

PCT Pub. Number WO2006/089064

Priority 60/653,233 15.02.05 US; 60/671,376 14.04.05 US

Filing date 14 February 2006

Wipo publication date 24 August 2006

International Classifications

A61K 38/20 (2006.01) Medicinal preparations containing peptides - Interleukins

A61K 31/475 (2006.01) - having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine

A61K 31/573 (2006.01)

A61K 31/675 (2006.01) - having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

A61K 31/704 (2006.01)

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

13 September 2007 PCT application entered the National Phase

  PCT publication WO2006/089064 Priority application(s): WO2006/089064

14 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006214247-Boron-containing small molecules

2006214242-Detection of biomarkers for neuropsychiatric disorders